Market
In Ecuador, alcachofa (artichoke, Cynara scolymus) is cultivated in highland areas and is commercially marketed, creating a local raw-material base relevant to artichoke-derived products. Artichoke leaf extract is present in Ecuador’s consumer market via retail “extracto” products, alongside imported finished supplements. Market access is primarily shaped by ARCSA pathways: supplements containing plant extracts require an ARCSA Notificación Sanitaria prior to importation and commercialization, while products positioned as processed natural medicinal products follow a Registro Sanitario pathway. Imports and authorizations are operationalized through SENAE’s Ventanilla Única Ecuatoriana (VUE), and processed-food labeling controls may apply under INEN’s RTE INEN 022 where relevant to the product’s classification and presentation.
Market RoleDomestic consumer and formulation market for artichoke-based supplements/natural products, supported by niche local offerings and regulated import of finished products
Domestic RoleBotanical extract used in consumer-facing natural products and dietary supplements subject to sanitary control
Risks
Regulatory Compliance HighImports that rely on sanitary registrations/notifications whose titularity corresponds to third parties may face rejection or non-acceptance at control points if not regularized with ARCSA; SENAE/ARCSA/COMEX communicated a VUE-related regularization deadline of 08 April 2026, after which non-authorized use may not be accepted.Before shipment, confirm the importer holds the correct ARCSA authorization/regularization for any third-party sanitary document used in VUE; do not schedule arrivals near the 08 April 2026 cutoff without written confirmation of compliance.
Regulatory Compliance HighDietary supplements that include plant extracts must obtain ARCSA Notificación Sanitaria prior to importation, storage, distribution, and commercialization; missing or incorrect filings can block market entry.Classify the product correctly as a supplement (if applicable) and secure ARCSA Notificación Sanitaria via the automated system before import; align product formulation, claims, and labeling to the approved notification.
Documentation Gap MediumBotanical ingredient dossiers can fail review or trigger compliance actions if the scientific name, plant part used, or qualitative-quantitative composition documentation is incomplete or inconsistent across filings and labels.Standardize the technical dossier and labeling master data (scientific name, plant part, and composition) and run a pre-submission QA check against ARCSA’s required declarations for supplements containing botanical extracts.
Labeling MediumIf the product presentation is regulated as a processed food rather than a supplement/natural medicinal product, labeling inspection requirements under INEN’s RTE INEN 022 may apply and create clearance delays if not prepared.Confirm the regulatory category (supplement vs processed food vs natural medicinal product) and prepare the correct labeling pathway and inspection documentation before import.
FAQ
Does artichoke extract sold as a dietary supplement need an ARCSA authorization in Ecuador?Yes. If the product is a dietary supplement (suplemento alimenticio), ARCSA’s rules require obtaining a Notificación Sanitaria before importation and commercialization, including for supplements that contain plant extracts.
What is the most time-critical customs risk for importing regulated products tied to sanitary notifications in early April 2026?SENAE, ARCSA, and COMEX warned that the use of sanitary registrations/notifications held by third parties must be regularized with ARCSA, with a stated deadline of 08 April 2026; after that date, non-authorized use may not be accepted and could block clearance.
Why does product classification matter for artichoke extract (supplement vs natural medicinal product)?Ecuador uses different ARCSA pathways depending on how the product is positioned. Supplements follow the Notificación Sanitaria process, while processed natural medicinal products follow a Registro Sanitario framework; choosing the wrong pathway can delay or prevent lawful commercialization.